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3 
Preface 
Total Synthesis is a field of Organic Chemistry that focuses on the construction of 
various compounds.  These compounds can be known, such is the case in the synthesis of 
natural products like Lactonamycin, or they can be creations of the imagination, like the 
Molecular Motor.  In both cases, this particular concentration of science involves a keen 
use of intellect as well as a substantial amount of creativity.   
 Many wonder whether or not synthesis is a worthwhile investment of time and 
money.   The most often used answer to this question is that synthesis produces helpful 
compounds like aspirin or antibiotics such as erythromycin.  Other good target molecules 
include scarce natural products for research purposes.  A good synthesis makes them 
inexpensive and easy to create industrially resulting in less expensive drugs and vitamins 
in the market for the consumer.  But in many, if not most cases the synthetic target proves 
to not be useful to the human body, generally due to toxicity or its presence as a 
carcinogen.   
 Aside from these compounds that end up being harmful, many compounds that 
seem to have little value to humanity  to begin with are synthesized anyway and are also 
heavily funded.  It is these compounds that receive a lot of criticism from both scientists 
and non-scientists, and it is these compounds that are often times the most important to 
total synthesis. 
 It is true that total synthesis when studied on its own has little value to humanity.  
There is little gained in synthesizing a natural product using chemistry that has been 
known for years.  The goal of total synthesis should not be to simply create the natural 
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product.  It should also be to develop new methodology along the way. It is through the 
development of new reactions that Chemistry progresses.    
This is not to say that methodology should be approached first, and then a multi-
step reaction sequence involving the new chemistry should be attempted.  This is not 
progress.  This is simply a proof of what has already been shown to occur.  This approach 
to Chemistry holds its head only slightly above those Chemists that consitently synthesize 
molecules without having discovered anything new.  There is a time and a place for a 
‘methodology then synthesis’ approach.  That place is Catalysis, a different speciality 
than total synthesis, one that deals with the improvement of synthetic method, not the 
discovery. 
Through careful design and synthesis of molecules, we as scientists learn the 
mechanics of chemistry.  We can learn how molecules interact with one another, and how 
different types of bonding are going to affect the chemistry of different reactions.  Using 
the results of published reactions and syntheses scientists can use the previously 
performed chemistry in application to their own molecules.  With the recent rise in 
publications being placed on the Internet it has become easier to stay up-to-date with 
current chemistry.   This in turn fosters an accelerated growth in the field and allows us to 
move forward into more complex reactions and target molecules at a faster pace.   
 With this progress chemists and biochemists hope to research and produce 
molecules that will have biological activity and will be applicable to the human body 
through shorter and more selective synthetic routes.  This growth in the field also 
provides chemists with the knowledge to go back to older syntheses and make them 
shorter and more cost efficient.  With the current political and public interest in 
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pharmaceuticals and healthcare costs, making syntheses shorter means lower costs to the 
consumers.  Thus establishing a reasoning behind the high investment in total synthesis. 
 Behind the advanced science of total synthesis lies a certain amount of creativity 
and knowledge that when applied correctly benefits everyone both in the science and in 
the community. 
It is with this in mind that I have opted to perform research in the field of natural 
product synthesis, and I propose this research for designation of Scholar of the College 
under the direction of Vanderslice Professor of Chemistry T. Ross Kelly. 
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Louisianin C: Introduction and Total Synthesis 
 
The louisianins are a family of four alkaloids isolated from a cultured broth of 
Streptomyces sp. WK-4028, which was isolated from a soil sample collected in 
Louisiana, U.S.A. 1  These molecules show anti-androgenic activity, primarily through the 
inhibition of the growth of testosterone-responsive SC 115 cells. (SC 115 cells are 
testosterone-responsive mouse mammary carcinomas.)2  Androgens aid the growth of the 
prostate gland.  This can be normal or abnormal cell growth.  In the case of abnormal 
androgenic cell production, the daughter cells that are produced are those that result in 
prostate cancer.  The louisianins have shown promise for the inhibition of androgenic cell 
production, and consequently could inhibit prostate cancer cell production.   
 The structures of louisianins A-D (1-4) as determined by Omura et al. (Figure 1) 
all have a common, centralized pyridine ring with two major constituents attached: a 
fused five-membered ring and an allylic side chain.  Louisianins A (1) and B (2) have a 
hydroxyl group present on the pyridine ring while C (3) and D (4) do not.2   
 
   
Figure 1.  Louisianins A, B, C, and D. 
                                                 
1 Another alkaloid, with the same carbon skeleton as the louisianins, has been isolated from a source from 
Uluday Turkey:  Henne P.; Grabley S.; Thiericke R.; Zeeck A. Ann. 1997, 5, 937.  
2 Takamatsu, S.; Kim, Y.-P.; Hayashi, M.; Furuhata, K.; Takayanagi, H.; Komiyama, K.; Woodruff, H. B; 
Omura, S. J. Antibiot. 1995, 48, 1090. 
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Omura et al. have shown conversion of 1 to 4, and in the process have isolated 3.  
At first 1 was originally found to be the most potent inhibitor of the SC 115 proliferation, 
while 3 and 4 showed only slight inhibition.  It was later found that 3 and 4 showed anti-
angiogenic activity and potently suppressed the tube formation of vascular endothelical 
cells in vitro.  While 1 was found to be produced in large amounts by a cultured 
fermentation broth of Streptomyces sp. WK-4028, 3 and 4 were found in only very small 
quantities.3   
 The discovery of the anti-angiogenic activity of louisianin C (3) and its scarcity in 
nature made the small alkaloid a good target for synthesis by the Kelly Lab. Aside from 
this, conversion of 3 to 4 was shown by Omura et al. to be possible in relatively high 
yield making 3 the more synthetically important target between the two choices.   
Research on the synthesis of louisianin C began 4 years ago with little success.  
With a newly developed retrosynthesis, the compound was completed within one year 
(2002) and the first completed total synthesis was recently accepted for publication 
(Scheme  1,  page 8).   
 The strategy behind the new synthetic pathway lies in the symmetry of the 
compounds in the first two steps and the key method for cyclization of the five-
membered ring.  The first step of the synthesis involved the protection of the reactive 
carbon (C-4) on the 3,5-dribromopyridine (5).  The carbon in the 4 position on the ring 
was lithiated to give 6, according to the method of Gu. 4 This was subsequently quenched 
with trimethylsilylchloride.  The trimethylsilyl group (TMS), now in place on the C-4 
position, acts not only as a bulky protector of the carbon para to the nitrogen, but it also 
                                                 
3 Sunazuka, T.; Zhi-Ming, T.; Harigaya, Y.; Takamatsu, S.; Hayashi, M.; Komiyama, K.; Omura, S. J. 
Antibiot. 1997 , 50, 274. 
4 Gu, Y. G.; Bayburt, E. K. Tetrahedron Lett. 1996, 37, 2565. 
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acts as a leaving group later in the synthesis.  With this site on the ring protected and the 
future leaving group in place, synthesis proceeded with a Stille coupling between two 
allylic groups and the C-3 and C-5 positions of the pyridine nucleus to yield compound 8 
in 96 % yield.5     
The next step involved the selective hydroxylation of only one of the allylic 
groups, thus destroying the symmetry of the compound.  This regioselective anti-
Markonikov hydroxylation was performed using 9-borabicyclo[3.3.1]nonane (9-BBN) 
and hydrogen peroxide.  Boron trifluoride diethyl etherate was used to protect the 
nitrogen atom in the pyridine ring, preventing the ring nitrogen from interacting with the 
one equivalent of 9-BBN adduct that followed.6  (Only one equivalent of 9-BBN was 
used to avoid the possibility of dihydroxylation.)  N,N,N',N'-tetramethylethylenediamine 
(TMEDA) was then added to quench the boron trifluoride diethyl etherate, removing it 
from the pyridine ring.  A slight white precipitate formed in the solution as evidence of 
this reaction.  This left only the 9-BBN to react with the hydrogen peroxide which 
yielded alcohol 9 in 43% yield with 45% recovery of starting material.  The yield for this 
step based on unrecovered starting material was 77%.   
The next step of the reaction involved the use of o-iodoxybenzoic acid (IBX).  
IBX is the precursor to the Dess-Martin periodinane reagent which oxidizes alcohols to 
aldehydes and ketones.  It was recently found that IBX performs the same function with 
similarly mild reaction conditions, and is much easier to make than Dess-Martin reagent.  
It is worth noting that, in many cases, an N-oxide can be formed when using IBX in the 
                                                 
5 The same coupling conditions were used as for the preparation of compound 14 in: Tilley, J. W.; Clader, 
J. W.; Zawoiski, S.; Wirkus, M.; LeMahieu, R. A.; O’Donnell, M.; Crowley, H.; Welton, A. F. J. Med. 
Chem. 1989, 32, 1814. 
6 Brown, H. C.; Vara-Prasad, J. V. N.; Zee, H.-S. J. Org. Chem. 1986, 51, 439. 
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presence of a nucleuphilic nitrogen atom.  Finney and More have used an Fmoc 
protecting group to prevent such from happening. 7  It was decided that with a primary 
alcohol as the target, the competing oxidation of the aromatic, pyridine nitrogen would 
not be a significant enough problem to add another step for protection.  In the end, the 
result was an 82% yield of 10 from 9 with no evidence of a side reaction TLC.8 
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Scheme 1. The synthesis of louisianin C (3). 
 
                                                 
7 More, J.D.; Finney, N.S. Org. Lett. 2002, 4, 3001. 
8 Frigerio, M.; Santagostino, M. Tetrahedron Lett. 1994 , 35, 8019. 
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Aldehyde 10 is the precursor to the key cyclization of the fused five-membered 
ring.  Tetrabutylammonium fluoride (TBAF) was the first reagent used for the attempted 
removal of the TMS group, however it was largely unsuccessful.  Tetrabutylammonium 
triphenylsilyldifluoride (TBAT) was then tried as a fluoride source.9  The benefits of 
using TBAT instead TBAF were that it was anhydrous and did not contain a naked (and 
basic) fluoride ion. 10  The reaction is presumed to have passed through a species similar 
to 11.11  It was here that the TMS protecting group acted as a leaving group, that lead to 
the cyclization of the aldehyde to yield the five-membered ring in compound 12 in 54% 
yield.   
The final step of the synthesis was from the literature of Omura et al.  IBX was 
originally attempted, but required heating and the use of multiple equivalents.  This may 
have been a cause of the ability of the pyridine nitrogen to compete for oxidation with an 
inhibited secondary alcohol such as the one present in 12.8 
  In any case, the results were inferior to that of the chromium trioxide oxidation 
published by Omura et al.3  Louisianin C (3) was isolated in an overall yield of 11% in 6 
steps.  The spectrometric data for our compound matches that published by Omura et al.  
This is the first synthesis of any of the louisianins and it confirms the structure proposed 
by Omura et al of louisianin C (3).2   
 
 
 
 
                                                 
9 Pilcher, A. S.; DeShong, P. J. Org. Chem. 1996, 61, 6901. 
10 Pilcher, A. S.; Ammon, H. L.; DeShong, P. J. Am. Chem. Soc. 1995, 117, 5166. 
11 Chuit, C; Corriu, R. J. P; Reye, C.; Young, J. C. Chem. Rev. 1993, 93, 1371. 
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Louisianin C: Experimental Data12 
 
Preparation of 3,5-Dibromo-4-(trimethylsilyl)pyridine (7): 
N
BrBr
TMS
7  
  A solution of 3,5-dibromopyridine (5) (2.00 g, 8.44 mmol) in dry tetrahydrofuran 
(67 mL) was added by cannula over 30 min to a stirring solution of lithium 
diisopropylamide [prepared by adding at –78 ºC 2.5 M n-butyllithium in hexanes (3.4 
mL, 8.6 mmol, 1.0 equiv) to diisopropylamine (1.21 mL, 8.61 mmol, 1.02 equiv) and 
stirring for 5 min] in THF (50 mL) under nitrogen at –78 °C.  After 5 min, trimethylsilyl 
chloride (1.50 mL, 11.8 mmol, 1.40 equiv) was added in one portion.  The reaction was 
monitored by TLC (silica, 49:1, hexanes:ethyl acetate) and, after a period of 25 min, the 
solution was quenched with a satd aqueous solution of ammonium chloride (10 mL) and 
was allowed to reach room temperature.4  The resulting mixture was extracted twice with 
diethyl ether.  The combined organic extracts were washed once with water and once 
with brine.  The organic phase was dried over anhyd magnesium sulfate, filtered, and 
concentrated in vacuo to afford the crude product as yellow crystals (2.40 g).  Flash 
column chromatography on silica gel (5 x 18 cm) using 49:1 hexanes:ethyl acetate as 
eluent gave the purified product (2.17 g, 83% yield): white flakes, mp 55-56 ºC; IR (KBr) 
2985, 2949, 2897, 1476, 1245, 1164 cm-1; 1H NMR (300 MHz, CDCl3) d 8.56 (s, 2H), 
0.57 (s, 9H); 13C NMR (100 MHz, CDCl3) d 150.3, 149.6, 128.1, 2.9; HRMS (ESI) calcd 
                                                 
12 For general procedures see: Kelly, T. R.; Lebedev, R. L. J. Org. Chem. 2002, 67, 2197. 
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C8H12Br2NSi [M+H]: 307.9106; found 307.9092; Anal. calcd for C8H11Br2NSi: C, 31.09; 
H, 3.59; N, 4.53; found C, 30.97; H, 3.31; N, 4.36.  
 
Preparation of 3,5-Diallyl-4-(trimethylsilyl)pyridine (8): 
N
TMS
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A solution of 3,5-dibromo-4-(trimethylsilyl)pyridine (7) (8.22 g, 26.6 mmol) and 
allyltributyltin (17.6 mL, 79.8 mmol, 3.00 equiv) in dimethylformamide (132 mL) was 
degassed by bubbling nitrogen through it for 30 min.  
Dichlorobis(triphenylphosphine)palladium(II) (1.87 g, 2.66 mmol, 10 mol %) was then 
added, and the reaction flask was heated at 100 ºC.5  When the reaction was complete [ca. 
20 h, TLC monitoring (silica, 20:1, hexanes:ethyl acetate)] the vessel was cooled to room 
temperature and the mixture was filtered through a pad (4 cm diameter, 4 cm height) of 
activated basic alumina (Brockmann I) on a fine porosity sintered glass funnel to remove 
the palladium and tin residues.  The basic alumina was washed with 400 mL of hexanes.  
The combined filtrate and washes were extracted three times with 1 M ammonium 
hydroxide to further remove tin residues, and the organic layer was washed 3 times with 
water, once with brine, dried over anhyd MgSO4 and concentrated in vacuo.  The pale 
yellow oil was purified by flash column chromatography on silica gel (6 x 22 cm) using a 
9:1 hexanes:ethyl acetate as eluent to yield a slightly yellow oil (6.15 g, 96% yield): pale 
yellow oil, IR (neat, NaCl) 3081, 3006, 2979, 2954, 2901, 1638, 1409, 1253 cm-1; 1H 
NMR (300 MHz, CDCl3) d 8.21 (s, 2H), 6.04-5.90 (m, 2H), 5.11 (dd, 2H, J = 10.2, 1.8 
13 
Hz), 4.86 (dd, 2H, J = 17.1, 1.8 Hz), 3.54-3.51 (m, 4H), 0.40 (s, 9H); 13C NMR (100 
MHz, CDCl3) d 148.8, 146.4, 139.2, 137.6, 116.2, 37.5, 3.0; HRMS (ESI) calcd 
C14H22NSi [M+H]: 232.1522; found 232.1524; Anal. calcd for C14H21NSi: C, 72.66; H, 
9.15; N, 6.05; found C, 72.76; H, 8.85; N, 5.89. 
 
Preparation of 3-Allyl-5-(3-hydroxypropyl)-4-(trimethylsilyl)pyridine (9):   
N
TMS
OH
9  
Boron trifluoride diethyl etherate (1.42 mL, 11.2 mmol, 1.00 equiv) was added 
dropwise over 5 min to a stirred solution of 3,5-diallyl-4-(trimethylsilyl)pyridine (8) 
(2.60 g, 11.2 mmol) in THF (112 mL) under nitrogen at 0 ºC.6  A 0.50 M solution of 9-
borabicyclo[3.3.1]nonane in THF (27 mL, 14 mmol, 1.2 equiv) was added dropwise, over 
15 min, at room temperature.  The mixture was left to stir overnight (15 h) to ensure a 
completed reaction.  The colorless solution was treated with N,N,N',N'-
tetramethylethylenediamine (0.85 mL, 5.6 mmol, 0.5 equiv), and after stirring for ~1 min 
a white precipitate formed.  The reaction vessel was cooled to 0 ºC, and a 2.5 M sodium 
hydroxide:35% hydrogen peroxide (1:1, v/v, 60.5 mL) was added in one portion.  The 
excess peroxide was quenched by addition of aliquots of a satd aqueous solution of 
sodium sulfite (60 mL) until peroxide indicator strips (EM Quant, Fisher cat no: 10011-1) 
were negative.  The aqueous mixture was then extracted three times with 20 mL portions 
of dichloromethane, and the combined organic extracts were washed with water and 
brine, dried over anhyd magnesium sulfate, filtered, and concentrated in vacuo to yield a 
14 
yellow oil (2.66 g).  The oil was purified by flash column chromatography on silica gel (4 
x 18 cm) using 7:3 ethyl acetate:hexanes as eluent.  Two purified compounds were 
isolated: the starting material 3,5-diallyl-4-(trimethylsilyl)pyridine (8) (1.16 g, 45% yield) 
and the desired product 3-allyl-5-(3-hydroxypropyl)-4-(trimethylsilyl)pyridine (9) (1.20 
g, 43%, 77% based on unrecovered 8): clear colorless oil, IR (neat, NaCl) 3342, 2979, 
2949, 1680, 1413, 1254 cm-1; 1H NMR (300 MHz, CDCl3) d 8.25 (s, 1H), 8.18 (s, 1H), 
6.02-5.91 (m, 1H), 5.10 (dd, 1H, J = 10.2, 1.7 Hz), 4.86 (dd, 1H, J = 17.1, 1.7 Hz), 3.72 
(t, 2H, J = 6.3 Hz), 3.52-3.49 (m, 2H), 2.86-2.80 (m, 2H), 1.86-1.78 (m, 2H), 1.82 (bs, 
1H), 0.42 (s, 9H); 13C NMR (100 MHz, CDCl3) d 148.2, 147.9, 146.1, 142.4, 139.6, 
137.5, 116.4, 61.9, 37.6, 36.2, 30.1, 3.1; HRMS (ESI) calcd for C14H23NOSi [M+H]: 
250.1627; found 250.1623. 
 
Preparation of 3-[5-Allyl-4-(trimethylsilyl)pyridin-3-yl]propanal (10):   
N
TMS
H
10
O
 
CAUTION! IBX is explosive under impact or upon heating to >200 ºC.13  o-
Iodoxybenzoic acid 14 (IBX, 1.16 g, 4.15 mmol, 1.2 equiv) was added to a stirred solution 
of 3-allyl-5-(3-hydroxypropyl)-4-(trimethylsilyl)pyridine (9) (861 mg, 3.46 mmol) in 
dimethylsulfoxide (8.3 mL) at room temperature,  giving a homogenous solution.  
Reaction progress was monitored by TLC (silica, ethyl acetate); after 1 h the starting 
material was consumed.  Water (10 mL) was then added to the solution and a white 
                                                 
13 Plumb, J. B.; Harper, D. J. Chem. Eng. News. 1990, July 16, 3. 
14 The IBX was prepared according to the following reference: Frigerio, M.; Santagostino, M.; Sputore, S. 
J. Org. Chem. 1999, 64, 4537. 
15 
precipitate formed which was removed by filtration through a pad (2 cm diameter, 1 cm 
height) of Celite® on a fine porosity sintered glass funnel.  The Celite® was rinsed with 
dichloromethane to ensure complete recovery of product.  The resulting combined 
biphasic filtrate and rinse was separated and the aqueous phase was extracted with two 15 
mL portions of additional dichloromethane. The combined organic layers were washed 
twice with 10 mL portions of water (to remove any excess DMSO) and brine, and dried 
over anhyd magnesium sulfate.  After concentration in vacuo, the oil was purified by 
flash column chromatography on a silica gel (2 x 17 cm) using 95:5 
dichloromethane:methanol as eluent to afford 3-[5-allyl-4-(trimethylsilyl)pyridin-3-
yl]propanal (10) (700 mg, 82% yield) as a clear colorless oil.  The product was stored 
under nitrogen at –24 ºC: clear colorless oil, IR (neat, NaCl) 2978, 2953, 2899, 1724, 
1412, 1255 cm-1; 1H NMR (300 MHz, CDCl3) d 9.84 (s, 1H), 8.24 (s, 1H), 8.22 (s, 1H), 
6.02-5.92 (m, 1H), 5.11 (dd, 1H, J = 10.2, 1.7 Hz), 4.86 (dd, 1H, J = 17.1, 1.7 Hz), 3.51 
(dd, 2H, J = 3.9, 1.7 Hz), 3.11-3.05 (m, 2H), 2.76 (t, 2H, J = 8.4 Hz), 0.41 (s, 9H); 13C 
NMR (100 MHz, CDCl3) d 199.9, 148.8, 147.5, 146.2, 140.5, 139.6, 137.4, 116.5, 46.6, 
37.5, 25.9, 3.0; HRMS (ESI) calcd for C14H22NOSi [M+H]: 248.1471 found 248.1472. 
 
Preparation of 6,7-Dihydro-4-(2-propenyl)-5H-cyclopenta[c]pyridin-5-ol (12):   
12
N
HO
 
A solution of 3-[5-allyl-4-(trimethylsilyl)pyridin-3-yl]propanal (10) (172 mg, 
0.696 mmol) in dry acetonitrile (11 mL) was transferred over 10 min by cannula under 
16 
nitrogen to a flame-dried flask containing tetrabutylammonium triphenylsilyldifluoride 
(TBAT, 756 mg, 1.39 mmol, 2.0 equiv) at room temperature.10  The reaction was 
refluxed at 85 ºC, and was monitored by TLC (silica, ethyl acetate).  After 1 h the starting 
material was consumed.  The reaction was cooled, and ten mL of 1 M sulfuric acid was 
added, and the solution was washed two times with dichloromethane to remove 
impurities.  The aqueous layer was then made basic (pH » 10) by addition of 2.5 M 
sodium hydroxide.  The milky aqueous layer was extracted three times with 10 mL 
portions of dichloromethane, the combined organic extracts were washed once each with 
water and brine, dried over anhyd magnesium sulfa te, and concentrated in vacuo to give a 
yellow oil (97 mg).  The oil was purified by preparative thin layer chromatography 
(silica, 95:5 dichloromethane:methanol) to afford 12 as a clear colorless oil (66 mg, 54% 
yield).  The spectra are in agreement with those reported for 12.  The HCl salt of 12 was 
prepared by bubbling HCl gas (generated by adding conc. sulfuric acid to ammonium 
chloride) into a solution of 12 in ether.  The ether was decanted, leaving behind a clear 
colorless oil, that was placed under high vacuum, which caused the HCl salt to 
crystallize: white needles, mp 134-135 ºC; IR (neat, NaCl) [M+H] 3300, 3039, 2972, 
2912, 2692 cm-1; 1H NMR [M+H] (300 MHz, CDCl3) d 8.36 (s, 1H), 8.28 (s, 1H), 6.02-
5.83 (m, 1H), 5.52 (dd, 1H, J = 6.6, 5.5 Hz), 5.29-5.23 (m, 1H), 5.17 (s, 1H), 3.78 (dd, 
2H, J = 7.2, 5.5 Hz), 3.41-3.25 (m, 1H), 3.11-2.95 (m, 1H), 2.71-2.58 (m, 1H), 2.36-2.29 
(m, 1H), 2.34 (bs, 1H); 13C NMR [M+H] (100 MHz, CDCl3) d 163.1, 143.1, 138.3, 
137.7, 134.4, 133.0, 119.1, 74.0, 34.8, 33.6, 28.3; HRMS (ESI) [M+H] calcd for 
C11H13NO: 176.1075, found: 176.1072.  
 
17 
Preparation of 6,7-Dihydro-4-(2-propenyl)-5H-cyclopenta[c]pyridin-5-one, 
louisianin C (3): 
N
3
Louisianin C
O
 
Following the procedure in reference 3, chromium trioxide (100 mg, 1.00 mmol, 
3.0 equiv) was added in one portion to a stirred solution of 6,7-dihydro-4-(2-propenyl)-
5H-cyclopenta[c]pyridin-5-ol (12) (59.1 mg, 0.337 mmol) in pyridine (3.2 mL) at room 
temperature.  The reaction was monitored by TLC (silica, ethyl acetate).  After 
consumption of the starting material (2 h) the reaction mixture was diluted with water (10 
mL).  The mixture was extracted twice with 10 mL portions of dichloromethane and the 
combined organic extracts were washed with water and brine and dried over anhyd 
magnesium sulfate.  The solvent was evaporated in vacuo to give a clear colorless oil.  
The oil was purified using preparative thin layer chromatography (silica, ethyl acetate) to 
afford 3 (42 mg, 72% yield) as a clear colorless oil:  IR (neat, NaCl) 2976, 2925, 1718 
cm-1; 1H NMR (400 MHz, CDCl3) d 8.76 (s, 1H), 8.47 (s, 1H), 6.02-5.92 (m, 1H), 5.09 
(dd, 1H, J = 6.8, 1.6 Hz), 5.06 (m, 1H), 3.80 (d, 2H, J = 6.8 Hz), 3.16 (apparent t, 2H, J = 
6.0 Hz), 2.72 (m, 2H); 13C NMR (100 MHz, CDCl3) d 206.9, 148.9, 147.9, 147.6, 139.5, 
135.2, 132.8, 116.7, 36.6, 32.7, 23.3; HRMS (ESI) calcd for C11H12NO [M+H]: 
174.0919; found 174.0913. The spectra are in agreement with those reported for 3.2  
 
 
18 
Azacridone A: Introduction and Progress toward 
Total Synthesis 
 
Azacridone A (13) is an example of an acridone type alkaloid that was isolated 
from the roots of Marsh grapefruit (C. paradisi).  Acridone molecules have been known 
to be biologically active, most importantly to humans as antitumor and antiviral agents.  
These molecules are most often found in Rutaceous (Citrus) plants. 
The molecule was isolated through extraction with refluxing acetone.  The 
extracts were separated by chromatograpy and then run on a preparative TLC to isolate 
azacridone A (13).   
What sets azacridone A (13) apart from other acridone derivatives is the presence 
of the second nitrogen in the leftmost ring.  This is particularly interesting because at the 
time of isolation the only other known acridone compound with a second nitrogen was a 
synthetic compound.  In other words, azacridone A (13) was the first naturally occurring 
aza-type acridone ever to be isolated.15   
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O OH
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Azacridone A
13
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O
Me
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Scheme 2.  Retrosynthesis of azacridone A (13). 
                                                 
15 Takemura, Y.; Isono, Y.; Ju-Ichi, M.; Omura, M.; Ito, C.; Furukawa, H. Chem. Pharm. Bull. 1993, 41, 
789. 
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This compound was chosen as a target for synthesis based on the possibility of 
biological activity and its somewhat complex four-ring structure that could easily be 
approached through the retrosynthesis as shown above (Scheme 2).     
Fragment B (15) is a known benzopyran moiety, and there is strong literature 
precedence to support the formation of fragment A (14).  The proposed synthesis of these 
two fragments is shown below (Scheme 3).   
Synthesis of fragment A (14) began with commercially available compound 3,4-
pyridinedicarboximide (16), which when treated with bromine, causes the imide ring to 
open and subsequently go through a Hoffman rearrangement.  The resulting compound 
was quenched with sulfuric acid, which precipitated an orange solid (17).16   
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Scheme 3.  The proposed synthesis of fragments A (14) and B (15). 
 
The remainder of the synthesis of 14 has yet to be attempted.  The proposed 
synthesis involves the conversion to an ester.  This will be performed not only to make 
                                                 
16 Chen, Q.; Deady, L. W. Aust. J. Chem.  1993, 46, 987. 
20 
the carbonyl less reactive, but also because of literature precedent that supports a ring 
closure between the ester and the aromatic portion of 15.17  With this in mind, the 
methylation of the amino group will most likely follow the esterification, which in turn 
will be followed by the reaction of the nitrogen with fragment B (15).  These last two 
steps could most likely be performed in any order.   
Synthesis of fragment B (19) began with starting material 18, the commercially 
available compound phloroglucinol.  This compound is known go through keto-enol 
tautomerization affording both the trihydroxyl form shown (Scheme 3), and its 1,3,5-
triketylcyclohexane tautomer.  Proton NMR shows that the predominant form of 18 is the 
aromatic tautomer.  Compound 19 was made by prenylating the ring at a position para to 
one of the hydroxyl groups. This was performed by the removal of the alcohol from 2-
methyl-3-buten-2-ol by boron trifluoride diethyl etherate.18  This presumably forms a 
delocalized positive charge on the primary carbon of the butene.  The aromatic ring then 
attacks to the primary carbocation to yield the prenylated compound 19, which like 18 
shows preference for the aromatic tautomer.    
It is believed that the benzopyran moiety 15 will have preference for the enol 
tautomer as well.   There is literature precedent for making 15 using a selenium bromide 
resin.  Other literature supports the possibility of forming the same compound using 
phenylselenium bromide, which is a more cost effective and time efficient process than 
the making and using of a resin.19  
                                                 
17 Wilthopf, P.; Lackner, H. Tetrahedron. 1987, 43, 4549. 
18 Lee, H.-H. J.Chem. Soc,. Perkin Trans. I. 1981, 3205.  
19 Nicolaou, K. C.; Pfefferkorn, J. A.; Roecker, A. J.; Cao, G.-Q.; Barluenga, S.; Mitchell, H. J. J. Am. 
Chem. Soc. 2000, 122, 9939.  
21 
The mechanism of the proposed addition of 14 to 15 is disputable due to the fact 
that the nitrogen can undergo a Michael addition to the aromatic ring or it can add to the 
tautomeric diketyl compound of 15.   This is dependent on the predominant tautomer of 
15.  As was previously discussed, it is presumed that the enol tautomer is the preferred 
form, however, if one draws the attempted Michael addition, one can see through electron 
pushing that there is no place to stabilize the anion produced by amino addition.  The 
only way the reaction could occur would be through an SN2 type addition, which is 
highly unlikely on an aromatic ring. For this reason the addition of fragment A (14) to 
fragment B (15) will initially be attempted with the ketyl approach in mind (Scheme 4). 
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Scheme 4. The proposed addition mechanism of 14 to 15. 
 
The next step will be the ring closure of fragments A (14) and B (15), which will 
be accomplished by the deprotonation of the carbon positioned ortho to the hydroxyl 
22 
group on the aromatic ring (22).17  The deprotonation will be performed using an 
organolithium reagent to be followed by acylation of the ester.  The resulting cyclization 
will be the completed alkaloid azacridone A (13). 
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Azacridone A: Experimental Data12 
 
Preparation of 3-aminoisonicotonic acid (17):   
N
O
17
NH2
OH
 
3,4-Pyridinedicarboximide (16, 1.00 g, 6.75 mmol) was added in portions to an 
ice-cold solution of sodium hypobromite, prepared by adding Br2 (393 µL, 7.63 mmol, 
1.13 equiv) dropwise to stirring of 10% NaOH (20 mL). A further 12 mL of 10 % NaOH 
were added to the resulting pale brown solution, and the reaction vessel was subsequently 
heated to 85 ºC over 30 min.  The reaction vessel was then held at 85 ºC for 10 minutes 
before being cooled to room temperature.  The resulting bright yellow solution was 
treated with 50% sulfuric acid solution at 0 ºC until a pH ~3 was achieved.  With the 
addition of the acid, a bright orange precipitate formed. The solid was filtered and 
washed with water (3 x 5 mL).  The resulting filtrate was neutralized, and the solid was 
dried under vacuum overnight to yield 18 (730 mg, 79% yield): orange solid, mp 300-302 
ºC; IR (KBr) 3379, 3272, 2490, 2144, 1625, 810 cm-1; 1H NMR (400 MHz, DMSO) d 
8.19 (s, 1H), 7.72 (d, 1H, J = 5.2 Hz), 7.45 (d, 1H, J = 4.8 Hz); 13C NMR (100 Hz, 
DMSO) d 168.4, 145.7, 140.5, 135.1, 122.9; LRMS (ESI) calcd for C6H7N2O2 [M+H]: 
139.05; found 139.07.  The spectra are in agreement with those reported for 17.16,20   
 
 
                                                 
20 For m.p. reference: Hurd, C. D.; Bethune, V. G. J. Org. Chem. 1970, 35, 1471. 
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Preparation of 2-(3-methylbut-2-enyl)phloroglucinol (19):   
OH
OHHO
19
 
Boron trifluoride diethyl etherate (1.5 mL, 12 mmol, 0.30 equiv) was added 
dropwise (5 min) to a dry stirring solution of phloroglucinol (18, 5.00 g, 39.7 mmol) in 
dioxane (25 mL) at 40 ºC under N2.  After 15 min, 2-methyl-3-buten-2-ol (2.1 mL, 20 
mmol, 0.50 equiv) was added dropwise (5 min) to the stirring solution at 40 ºC.  After 1 
h, the reaction was cooled to room temp, and the solution was extracted with diethyl ether 
(2 x 20 mL) and water (25 mL).  The organic layers were combined, washed with water 
(4 x 15 mL) and brine (15 mL), dried over MgSO4, and concentrated in vacuo.  The crude 
mixture was purified using column chromatography (silica gel, 4 x 17 cm) with ethyl 
acetate:benzene (gradient 1:20-1:5) as eluent.  The white needles isolated were then 
recrystallized (CHCl3) to yield 19 (770 mg, 10 %)18: white needles, mp 98-100 ºC; IR 
(KBr) 3235, 1615, 1043 cm-1; 1H NMR (400 MHz, DMSO) d 8.79 (s, 2H),  8.69 (s, 1H), 
5.74 (s, 2H), 5.10 (bt, 1H, J = 6.4 Hz), 3.02 (d, 2H, J = 6.8 Hz), 1.65 (s, 1H), 1.58 (s, 
1H); 13C NMR (100 MHz, DMSO) d 156.1, 155.6, 128.3, 124.6, 105.2, 94.1, 25.7, 21.8, 
17.9; LRMS calcd 195.10; found 195.14 (trace amount); LRMS calcd C11H14O3Na [M + 
Na]: 217.08; found 217.12.21,22 
 
                                                 
21 Proton NMR reference was performed in acetone.  This was confirmed and then the product was run in 
DMSO for better peak resolution of the alcohols: Fukai, T.; Fujimoto, T.; Hano, Y.; Nomura, T.; Uzawa, J. 
Heterocycles. 1984, 22, 2805. 
22 For IR and m.p. reference see: Finnegan, R. A.; Morris, M. P.; Djerassi, C. J. Org. Chem. 1961, 26, 1180. 
25 
 
 
 
 
 
 
 
 
 
 
NMR Spectra for 
Louisianin C and Azacridone A Compounds 
















